Questors Techology
Drug Supply Chain Security Act (DSCSA Blockchain)
FDA’s Drug Supply Chain Security Act (2013) FDA is working with the selected participants to explore and evaluate methods to enhance the safety and security of the drug supply chain. DSCSA is a law to be implemented by 2023 as a Blockchain to drug supply chain stakeholders, all US GMP manufacturer to distributors are developing the serialization, interoperable system that secures production to be traceable to the consumers.
Under the DSCSA Blockchain program, FDA and global compliance with regulatory requirements or an endorsement of a particular technology, system, or other approach used in the pilots reflect the diversity of the supply chain including large and small entities from all industry sectors to safeguard the future of healthcare, manufacturers in the supply chain. KRFI aims to implement Questors: DSCSA Blockchain to partner nationally, to identify and trace the Opiate, Opioid, controlled substances manufacturers globally for fake medicine and prescription drugs that are distributed illegally within the United States. DSCSA Blockchain serves as a validation program of Seeds to Products, which supports the regional Drug Policy countries joining in this global health initiative.
.webp)
KRFI aims to stem the tide of opioid overdose deaths and addiction, by bringing transparency to the entire drug supply chain ecosystem.